相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation
Meng Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes
Robert B. Wilson et al.
PLEURA AND PERITONEUM (2019)
Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia
F. Peng et al.
ONCOGENE (2018)
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells
Wenjia Zhang et al.
PLOS ONE (2017)
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents
Elise Saunier et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Targeting the tumour microenvironment in ovarian cancer
Jean M. Hansen et al.
EUROPEAN JOURNAL OF CANCER (2016)
Hypoxia and metabolic adaptation of cancer cells
K. L. Eales et al.
ONCOGENESIS (2016)
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
Angela Rynne-Vidal et al.
CANCERS (2015)
Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
Benoit Thibault et al.
CANCER AND METASTASIS REVIEWS (2014)
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer
Karen Kar-Loen Chan et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Combined Targeting of PDK1 and EGFR Triggers Regression of Glioblastoma by Reversing the Warburg Effect
Kiran Kumar Velpula et al.
CANCER RESEARCH (2013)
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
Hoon Hur et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
CYLD Inhibits Melanoma Growth and Progression through Suppression of the JNK/AP-1 and β1-Integrin Signaling Pathways
Hengning Ke et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Targeting Gonadotropin-releasing Hormone Receptor Inhibits the Early Step of Ovarian Cancer Metastasis by Modulating Tumor-mesothelial Adhesion
Lydia W. T. Cheung et al.
MOLECULAR THERAPY (2013)
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Joanna Kaplon et al.
NATURE (2013)
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
M. K. Y. Siu et al.
ONCOGENE (2013)
Epithelial Ovarian Cancer-Induced Angiogenic Phenotype of Human Omental Microvascular Endothelial Cells May Occur Independently of VEGF Signaling
Boleslaw K. Winiarski et al.
TRANSLATIONAL ONCOLOGY (2013)
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Gopinath Sutendra et al.
FRONTIERS IN ONCOLOGY (2013)
Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration
Christine A. Caneba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts
Christian Fabian et al.
FEBS JOURNAL (2012)
Glucose Oxidation Modulates Anoikis and Tumor Metastasis
Sushama Kamarajugadda et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Almut Schulze et al.
NATURE (2012)
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
Anirban K. Mitra et al.
CANCER DISCOVERY (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism
Taro Hitosugi et al.
MOLECULAR CELL (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer
Miranda Y. Fong et al.
PLOS ONE (2011)
Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
Isaiah G. Schauer et al.
NEOPLASIA (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients
Michelle K. Y. Siu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Senescent Peritoneal Mesothelial Cells Promote Ovarian Cancer Cell Adhesion The Role of Oxidative Stress-Induced Fibronectin
Krzysztof Ksiazek et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Vascular Cell Adhesion Molecule-1 Is a Regulator of Ovarian Cancer Peritoneal Metastasis
Jill K. Slack-Davis et al.
CANCER RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration
Katharine L. Sodek et al.
BMC CANCER (2008)
PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer
S. M. Wigfield et al.
BRITISH JOURNAL OF CANCER (2008)
Loss of E-cadherin promotes ovarian cancer metastasis via alpha(5)-integrin, which is a therapeutic target
Kenjiro Sawada et al.
CANCER RESEARCH (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells
Thomas McFate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M. Merritt et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases
Marie A. Bogoyevitch et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2006)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
RAC1/P38 MAPK signaling pathway controls beta 1 integrin-induced interleukin-8 production in human natural killer cells
F Mainiero et al.
IMMUNITY (2000)
分享论文
